naltrexone and enkephalin-leu, ala(2)-arg(6)-

naltrexone has been researched along with enkephalin-leu, ala(2)-arg(6)- in 3 studies

Research

Studies (3)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (33.33)18.2507
2000's2 (66.67)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Maslov, LN; Naryzhnaya, NV; Tam, SW1
Bespalova, ZhD; Lasukova, TV; Maslov, LN; Nagase, H; Oldgen, P; Rice, KK1
Kolar, F; Krylatov, AV; Lishmanov, YB; Maslov, LN; Naryzhnaya, NV; Ovchinnikov, MV; Stakheev, DL1

Other Studies

3 other study(ies) available for naltrexone and enkephalin-leu, ala(2)-arg(6)-

ArticleYear
Ligands for opioid and sigma-receptors improve cardiac electrical stability in rat models of post-infarction cardiosclerosis and stress.
    Life sciences, 1999, Volume: 65, Issue:1

    Topics: Animals; Anti-Arrhythmia Agents; beta-Endorphin; Disease Models, Animal; Dynorphins; Enkephalin, Leucine-2-Alanine; Heart; Immobilization; Ligands; Morphine; Myocardial Infarction; Myocardium; Naloxone; Naltrexone; Narcotic Antagonists; Oligopeptides; Piperidines; Pyrrolidines; Rats; Receptors, Opioid; Receptors, Opioid, delta; Stress, Physiological; Ventricular Fibrillation

1999
Delta-opioid receptor antagonists exhibit properties of partial delta-receptor agonists in isolated perfused heart.
    Bulletin of experimental biology and medicine, 2004, Volume: 138, Issue:4

    Topics: Animals; Enkephalin, D-Penicillamine (2,5)-; Enkephalin, Leucine; Enkephalin, Leucine-2-Alanine; Heart; In Vitro Techniques; Male; Myocardial Contraction; Myocardial Ischemia; Naltrexone; Oligopeptides; Perfusion; Quinolines; Rats; Rats, Wistar; Receptors, Opioid, delta

2004
Myocardial resistance to ischemic and reperfusion injuries under conditions of chronic administration of opioid receptor agonists and antagonists.
    Bulletin of experimental biology and medicine, 2008, Volume: 145, Issue:6

    Topics: Animals; Azocines; Enkephalin, Leucine-2-Alanine; Heart; Male; Myocardial Reperfusion Injury; Naltrexone; Narcotic Antagonists; Piperazines; Pyrrolidines; Rats; Rats, Wistar; Receptors, Opioid; Receptors, Opioid, delta; Receptors, Opioid, kappa; Receptors, Opioid, mu

2008